West Pharmaceutical Services, Inc. with ticker code (WST) now have 9 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between 449 and 290 calculating the mean target price we have $370.89. Given that the stocks previous close was at $382.47 this would indicate that there is a downside of -3.0%. It’s also worth noting that there is a 50 day moving average of $357.86 and the 200 day MA is $293.31. The market capitalization for the company is 28.09B. The stock price is currently at: 378.33 USD
The potential market cap would be $27,237,777,993 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 51.97, revenue per share of 38.74 and a 13.22% return on assets.
West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates through two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment solutions, and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
